What Is Cell Therapy?

Cell therapy, also known as cellular therapy or cytotherapy, is the treatment of disease by transferring living cells into a patient, either to replace tissue that has been lost or to supply a biological function the patient's own cells cannot perform. The transferred cells are the active agent, which distinguishes cell therapy from conventional pharmaceuticals: the product is a population of living, dividing, responsive cells rather than a defined molecule. When those cells have been genetically modified before transfer, the product falls under gene therapy regulation as well.

Hematopoietic stem cell transplantation, first performed successfully in the 1950s and 1960s, is the oldest and most widely used form. The field expanded through the 1990s with cultured skin substitutes and chondrocyte implantation, and expanded again with engineered immune cells for cancer. Cells may be autologous, taken from the patient and returned after processing, or allogeneic, taken from a donor and given to another individual, a distinction that determines immunosuppression requirements, manufacturing logistics, and cost structure.

Engineered Immune Cell Therapy

The most prominent current example is chimeric antigen receptor T-cell therapy. A patient's T cells are collected by leukapheresis, transduced with a viral vector encoding a synthetic receptor that recognizes a tumor surface antigen such as CD19 or BCMA, expanded in culture, and reinfused after lymphodepleting chemotherapy. The receptor fuses an antibody-derived binding domain to intracellular signaling and costimulatory domains, so antigen binding activates the cell without the usual major histocompatibility restriction. The FDA's guidance on considerations for the development of CAR T cell products sets out how these are classified and what evidence supports approval. Several products are now licensed for B-cell leukemias, lymphomas, and multiple myeloma, and characteristic toxicities including cytokine release syndrome and neurotoxicity are managed with defined grading and treatment protocols.

Stem Cells and Regenerative Applications

A second branch aims to restore tissue rather than to attack disease. Hematopoietic stem cells rebuild marrow after ablative conditioning. Mesenchymal stromal cells are investigated for their immunomodulatory secretome rather than for engraftment. Pluripotent stem cells, whether embryonic or induced from adult somatic cells by reprogramming, can be differentiated toward retinal pigment epithelium, cardiomyocytes, or dopaminergic neurons and delivered to the corresponding tissue. The National Institutes of Health overview of regenerative medicine frames the aim as creating living functional tissue to repair or replace function lost to damage, disease, or congenital defect. Combining cells with a scaffold, growth factors, and mechanical conditioning moves the work into tissue engineering proper.

Manufacturing and Quality Control

Because the product is alive, manufacturing is inseparable from the therapy itself. A cell therapy process involves collection, selection, activation, transduction or differentiation, expansion in bioreactors, formulation, cryopreservation, and cold chain distribution, with a defined vein-to-vein time. Closed automated systems reduce contamination risk and operator variability, and inline sensors track viability, metabolite concentration, and cell density. Release testing must establish identity, purity, potency, and sterility on a batch that may consist of a single patient's cells and cannot be sampled destructively at will. A National Academies study on navigating the manufacturing process and ensuring the quality of regenerative medicine therapies sets out where potency assay development and process comparability remain the limiting steps.

Applications

Cell therapy is applied across several areas of medicine and bioengineering, including:

• Hematologic malignancy treatment with engineered T cells
• Bone marrow and hematopoietic stem cell transplantation
• Cartilage, skin, and corneal tissue repair
• Cardiac and neurological regenerative programs
• Autoimmune disease modulation with stromal cells
• Bioprocess engineering for automated cell manufacturing
• Cryopreservation and cold chain logistics technology